Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMed

3D printed O 2 -generating scaffolds enhance osteoprogenitor- and type H vessel recruitment during bone healing.

Sarkar N., Zhao J., Zhang NY., Horenberg AL., Grayson WL.

Animal Study on Chronic Wound, published in Acta Biomater (2024) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Acta Biomater (2024)
Country
England
Reported sample size
—
Source database
PubMed
PMID
39009209
PMCID
PMC11405102
DOI
10.1016/j.actbio.2024.07.011
Citations
9

Abstract (original English)

Oxygen (O 2 )-delivering tissue substitutes have shown tremendous potential for enhancing tissue regeneration, maturation, and healing. As O 2 is both a metabolite and powerful signaling molecule, providing controlled delivery is crucial for optimizing its beneficial effects in the treatment of critical-sized injuries. Here, we report the design and fabrication of 3D-printed, biodegradable, O 2 -generating bone scaffold comprising calcium peroxide (CPO) that once hydrolytically activated, provides long-term generation of oxygen at a controlled, concentration-dependent manner, and polycaprolactone (PCL), a hydrophobic polymer that regulate the interaction of CPO with water, preventing burst release of O 2 at early time points. When anoxic conditions were simulated in vitro, CPO-PCL scaffolds maintained the survival and proliferation of human adipose-derived stem/stromal cells (hASCs) relative to PCL-only controls. We assessed the in vivo osteogenic efficacy of hASC-seeded CPO-PCL scaffolds implanted in a non-healing critical-sized 4-mm calvarial defects in nude mice for 8 weeks. Even without exogenous osteoinductive factors, CPO-PCL scaffolds demonstrated increased new bone volume compared to PCL-only scaffolds as verified by both microcomputed tomography analysis and histological assessments. Lastly, we employed a quantitative 3D lightsheet microscopy platform to determine that

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Printing, Three-DimensionalTissue ScaffoldsAnimalsOxygenHumansPolyestersMice, NudeOsteogenesisBone RegenerationMice

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research